Association Between Lung Immune Prognostic Index and Durvalumab Consolidation Outcomes in Patients With Locally Advanced Non‐Small‐Cell Lung Cancer
- Resource Type
- Article
- Authors
- Riudavets, Mariona; Auclin, Edouard; Mosteiro, Miguel; Dempsey, Naomi; Majem, Margarita; Prelaj, Arsela; López-Castro, Rafael; Bosch-Barrera, Joaquim; Pilotto, Sara; Escalera, Elena; Tagliamento, Marco; Mosquera, Joaquin; Zalcman, Gérard; Aboubakar Nana, Frank; Ponce, Santiago; Albarrán-Artahona, Víctor; Dal Maso, Alessandro; Spotti, Martina; Mielgo, Xabier; Mussat, Elodie; Reyes, Roxana; Benítez, Jose-Carlos; Lupinacci, Lorena; Duchemann, Boris; De Giglio, Andrea; Blaquier, Juan Bautista; Audigier-Valette, Clarisse; Scheffler, Matthias; Nadal, Ernest; Lopes, Gilberto; Signorelli, Diego; Garcia-Campelo, Rosario; Menis, Jessica; Bluthgen, Virginia; Campayo, Marc; Recondo, Gonzalo; Besse, Benjamin; Mezquita, Laura; Planchard, David
- Source
- In Clinical Lung Cancer May 2024 25(3):233-243
- Subject
- Language
- ISSN
- 1525-7304